Navigation Links
New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
Date:9/29/2009

DURHAM, N.C., Sept. 29 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that a new presentation for investors by company chairman and CEO, Chris Stern, is now available on the company website. The link to the presentation can be found under the "Presentations" heading on the Investor Relations section of the website at www.oxybiomed.com. It can also be accessed via the following direct link: https://oxybiomed.webex.com/oxybiomed/ldr.php?AT=pb&SP=MC&rID=233172&rKey=d75ac2ab8a411e23

The presentation is the same one that Stern will present at an investor conference in Zurich on Sept. 30, 2009. While the Zurich presentation will be in German, the presentation on the website is in English.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has under development a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte®) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes wounds and ulcers, and cosmetic applications. More information is available at www.oxybiomed.com.

SOURCE Oxygen Biotherapeutics, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
2. Senexis and O2H (Oxygen Healthcare) Announce Medicinal Chemistry Collaboration
3. Finesse Introduces TruFluor(TM) DO, a Single-Use Optical Dissolved Oxygen Sensor and Transmitter
4. Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
5. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
6. Oxygen Biotherapeutics, Inc. Expands Board of Directors
7. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
8. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
9. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
10. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
11. Brain Monitor Eliminates Need for Routine Oxygen With Propofol - Friedberg's Triad Unveiled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... Today, ... professionals, has announced the addition of 5 new courses to its prospectus. These ... with Regulation 21 CFR Part 11 on Electronic Records and Electronic Signatures (Part ...
(Date:9/20/2017)... CT (PRWEB) , ... September 20, 2017 , ... ... announced today that it has appointed Vishwas Paralkar to the role of chief ... tumor targeting technology. He will report to Cybrexa’s president and CEO, Per Hellsund. ...
(Date:9/20/2017)... ... September 20, 2017 , ... From industry leaders, sports ... after standard medicine failed. Many of these people had lost all hope. ... Free Download (pdf) , “Neil takes readers on a riveting ...
(Date:9/19/2017)... ... September 19, 2017 , ... A ... funded early-stage tech companies. “Grit” author Angela Duckworth and her team at Character ... community is Cooley, an international law firm with decades of experience supporting high-growth ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):